Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Keros Therapeutics (KROS) Interest Coverage Ratio (2019 - 2022)

Keros Therapeutics filings provide 4 years of Interest Coverage Ratio readings, the most recent being 24126.0 for Q1 2022.

  • On a quarterly basis, Interest Coverage Ratio fell 53.0% to 24126.0 in Q1 2022 year-over-year; TTM through Dec 2022 was 114790.0, a 714.5% decrease, with the full-year FY2022 number at 114790.0, down 714.5% from a year prior.
  • Interest Coverage Ratio hit 24126.0 in Q1 2022 for Keros Therapeutics, down from 4866.0 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 775.33 in Q3 2019 to a low of 24126.0 in Q1 2022.
  • Median Interest Coverage Ratio over the past 4 years was 8444.0 (2020), compared with a mean of 9954.99.
  • Biggest five-year swings in Interest Coverage Ratio: crashed 723.39% in 2020 and later skyrocketed 63.39% in 2021.
  • Keros Therapeutics' Interest Coverage Ratio stood at 775.33 in 2019, then crashed by 1614.23% to 13291.0 in 2020, then skyrocketed by 63.39% to 4866.0 in 2021, then plummeted by 395.81% to 24126.0 in 2022.
  • The last three reported values for Interest Coverage Ratio were 24126.0 (Q1 2022), 4866.0 (Q4 2021), and 20197.0 (Q3 2021) per Business Quant data.